These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12662005)

  • 1. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment.
    Eur Respir J; 2003 Mar; 21(3):478-82. PubMed ID: 12662005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
    Jenkins PA; Campbell IA;
    Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of Mycobacterium malmoense isolation in The Netherlands.
    Hoefsloot W; van Ingen J; de Lange WC; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Eur Respir J; 2009 Oct; 34(4):926-31. PubMed ID: 19386689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
    Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
    Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
    Huet D; Godbert B; Hermann J; Zordan JM; Chabot F; Andréjak C
    Rev Mal Respir; 2017 Mar; 34(3):257-261. PubMed ID: 27639948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
    Pigem R; Cairó M; Martínez-Lacasa X; Irigoyen D; Miró JM; Acevedo J; Fernández J; Alsina-Gibert M
    J Am Acad Dermatol; 2013 Oct; 69(4):e192-3. PubMed ID: 24034397
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
    Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
    Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man.
    Brereton AS; El Teraifi H
    BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22602841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review.
    Zaugg M; Salfinger M; Opravil M; Lüthy R
    Clin Infect Dis; 1993 Apr; 16(4):540-9. PubMed ID: 8390306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium malmoense infections in Scotland: an increasing problem.
    France AJ; McLeod DT; Calder MA; Seaton A
    Thorax; 1987 Aug; 42(8):593-5. PubMed ID: 3660312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.